Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

about

Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

Item

http://www.wikidata.org/entity/Q58701126

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 24 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Characterization of Effects of ...... s of Meropenem and Vaborbactam

@en

Characterization of Effects of ...... s of Meropenem and Vaborbactam

@nl

type

Item

label

Characterization of Effects of ...... s of Meropenem and Vaborbactam

@en

Characterization of Effects of ...... s of Meropenem and Vaborbactam

@nl

prefLabel

Characterization of Effects of ...... s of Meropenem and Vaborbactam

@en

Characterization of Effects of ...... s of Meropenem and Vaborbactam

@nl

P1476

Ex Vivo Characterization of Ef ...... s of Meropenem and Vaborbactam

@en

P2093

David Griffith

http://www.w3.org/2001/XMLSchema#string

Elizabeth Alexander

http://www.w3.org/2001/XMLSchema#string

Jeffery Loutit

http://www.w3.org/2001/XMLSchema#string

Jeffrey Lipman

http://www.w3.org/2001/XMLSchema#string

Nermin Karamujic

http://www.w3.org/2001/XMLSchema#string

Saurabh Pandey

http://www.w3.org/2001/XMLSchema#string

Stephanie Durso

http://www.w3.org/2001/XMLSchema#string

Steven C Wallis

http://www.w3.org/2001/XMLSchema#string

Suzanne Parker

http://www.w3.org/2001/XMLSchema#string

P2860

Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration

Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.

Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration.

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects

A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.

Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study.

Use of an in vitro model of renal replacement therapy systems to estimate extracorporeal drug removal.

Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials.

P31

scholarly article

P356

10.1128/AAC.01306-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason A. Roberts

Fekade Bruck Sime

P577

2018-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30082292

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

infectious disease

P932

6153839

http://www.w3.org/2001/XMLSchema#string